NANOTECHNOLOGY-BASED DRUG DELIVERY SYSTEMS: ENHANCING BIOAVAILABILITY AND REDUCING SYSTEMIC SIDE EFFECTS

Abstract

Nanotechnology-based drug delivery systems have emerged as a promising approach in modern pharmaceutical sciences to overcome the limitations of conventional dosage forms. Many therapeutic agents suffer from poor bioavailability, low solubility, rapid degradation, and non-specific distribution, which often lead to reduced therapeutic efficacy and increased systemic side effects. The application of nanotechnology enables the development of advanced delivery systems such as nanoparticles, liposomes, nanoemulsions, and polymeric nanocarriers that can improve drug stability and controlled release profiles.

These nanocarriers facilitate targeted drug delivery by enhancing cellular uptake and allowing site-specific accumulation of the drug at the desired location. As a result, higher drug concentrations can be achieved at the target site while minimizing exposure to healthy tissues. This targeted approach significantly enhances bioavailability and reduces systemic toxicity and adverse effects. Furthermore, nanotechnology-based systems allow dose reduction and prolonged therapeutic action, thereby improving patient compliance.

In conclusion, nanotechnology-based drug delivery systems represent a highly effective strategy for enhancing bioavailability and reducing systemic side effects. Continued research and clinical evaluation of these systems are essential for their successful translation into safe and effective pharmaceutical products.